Annual Research Day 8 April 2016

HIV and TB:

New Horizons for Treatment and Prevention Research in Zimbabwe;

with A Special Focus on Adolescents

Session I:    Completed study results and updates

  • A5273-CROI 2016 Primary Results Final Out: Options for Second Line HIV Combination Therapy-Anthony Chisada
  • ACTG A5274 (REMEMBER study): Empiric versus Standard of Care TB Treatment-Wadzanai Samaneka
  • P1084s: Impact of Maternal Tenofovir Exposure on Newborn Bone Mineral Content – Bone and Kidney Health sub-study of PROMISE-Lynda Stranix-Chibanda
  • ZIMCHIC:Contraceptive Hormonal Induced Changes in the vaginal mucosa –ZIMCHIC study status:-Felix Mhlanga
  • HPV Update: Ngaatendwe R Manyere
  • MTN 020 ASPIRE: Safety and Efficacy of Dapivirine Intra Vaginal Ring for HIV-1 Prevention in Women- Portia Hunidzarira

Session II: Biomedical HIV prevention methods for adolescents and women

  • Biomedical HIV prevention :Why the focus on adolescents? – M Bwakura
  • Key note address: Key considerations for successful HIV prevention programmes
  • MTN 034: UZ-UCSF HIV Prevention Research Agenda for Adolescents- Portia Hunidzarira
  • HPTN 082: UZ-UCSF HIV Prevention Research Agenda for Adolescents- Portia Hunidzarira
  • IMPAACT 2009: UZ-UCSF HIV Prevention Research Agenda for Adolescents- Lynda Stranix-Chibanda
  • Antibody Mediated HIV Prevention: Antibody Mediated HIV Prevention- Nyaradzo Mgodi

Session III: TB session